checkAd
    Startseite > Aktien > Arbutus Biopharma > Nachrichten
    Arbutus Biopharma
    Aktie
    ISIN: CA03879J1003 WKN: A14XMD SYM: I9DN Land Kanada
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    2,9400
     
    EUR
    -0,27 %
    -0,0080 EUR
    Letzter Kurs 14.06.24 Tradegate
    Geldkurs
    14.06.24
    2,9040
     
    EUR
    688 STK
    Briefkurs
    14.06.24
    2,9700
     
    EUR
    673 STK

    Arbutus Biopharma Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
    06.06.24 · globenewswire · Arbutus Biopharma
    Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
    05.06.24 · globenewswire · Arbutus Biopharma
    Arbutus to Participate in Jefferies Global Healthcare Conference
    29.05.24 · globenewswire · Arbutus Biopharma
    Arbutus to Present Imdusiran Data at EASL Congress 2024
    22.05.24 · globenewswire · Arbutus Biopharma
    Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
    17.05.24 · Business Wire (engl.) · Arbutus Biopharma
    Arbutus to Participate in Two Upcoming Investor Conferences
    07.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
    18.04.24 · globenewswire · Arbutus Biopharma
    Die größten Aufsteiger der Woche vom 03.04.-10.04.2024 in der wO Community
    10.04.24 · wO Chartvergleich · Bayer
    Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
    04.04.24 · globenewswire · Arbutus Biopharma
    Arbutus to Participate in Two Upcoming Investor Conferences
    08.03.24 · globenewswire · Arbutus Biopharma